Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 151 publications
Reply to: "Beyond Response Rates: Interpreting Long-Term Benefit in CheckMate 743" and "Beyond Statistical Significance: Methodological Fragility and Censoring Bias in the 5-Year Update of CheckMate 743".
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 10, 2026
Erratum: Five-Year Clinical Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Unresectable Pleural Mesothelioma in CheckMate 743.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 02, 2026
Breast Implant-Associated Malignancies: Current Recommendations for Workup and Management.
Journal: Plastic and reconstructive surgery
Published: April 29, 2026
Real-World Experience of Tarlatamab in Extensive-Stage Small Cell Lung Carcinoma Showed Promising Systemic and Intracranial Efficacy With Higher Neurologic Toxicity.
Journal: JCO precision oncology
Published: April 23, 2026
A plain language summary of the updated results from the PHAROS study: the combination of encorafenib plus binimetinib for people with BRAF V600E-mutant metastatic non-small cell lung cancer.
Journal: Future oncology (London, England)
Published: March 30, 2026
Clinical Validation of Tissue and Liquid Companion Diagnostics for BRAF V600E Detection in Non-Small Cell Lung Cancers from the PHAROS Study.
Journal: Cancer research communications
Published: March 03, 2026
Five-Year Clinical Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Unresectable Pleural Mesothelioma in CheckMate 743.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 24, 2026
Development and Implementation of a Machine Learning Model for Prediction of Surgical Case Duration.
Development and Implementation of a Machine Learning Model for Prediction of Surgical Case Duration.
Journal: Joint Commission journal on quality and patient safety
Published: January 06, 2026
Long-term outcomes after proton therapy vs. intensity-modulated photon radiotherapy with concurrent chemotherapy for locally advanced non-small-cell lung cancer: post-hoc analysis of a prospective randomized trial.
Journal: International journal of radiation oncology, biology, physics
Published: December 02, 2025
Long-Term Outcomes After Proton Therapy Versus Intensity Modulated Photon Radiation Therapy With Concurrent Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer: Post Hoc Analysis of a Prospective Randomized Trial.
Journal: International journal of radiation oncology, biology, physics
Published: December 02, 2025
Last Updated: 09/26/2026